Stepping into a New Decade: EHL BIO’s New Headquarters and Research Center in Apgujeong

Quick answer

EHL BIO has relocated its headquarters and EHL Cell Center to the new EHL Building in Apgujeong, Gangnam, Seoul, to expand its research and medical service capabilities for its 10th anniversary. This hub integrates advanced GMP cell production technology and state-of-the-art facilities in one location.

Key takeaways

Located in the heart of Apgujeong, Gangnam-gu, Seoul, ensuring convenient access for patients and medical partners.
Equipped with Class 100 cleanroom facilities and advanced GMP-certified cell production technology.
Capable of producing up to 6,000 cell lots annually under rigorous quality control systems.
Serves as the R&D hub for future cell therapy and Exosome innovations.

A New Vision for the 10th Anniversary at EHL Building, Apgujeong

In 2022, EHL BIO reached a significant milestone by relocating its headquarters and EHL Cell Center to a new facility in Apgujeong, Gangnam-gu, Seoul—a strategic hub for medicine and beauty in the Republic of Korea. This relocation represents more than just a space expansion; it is an upgrade in quality of life and research standards to become a global leader in regenerative medicine.

Located in the heart of Apgujeong, the center is easily accessible via Apgujeong Station Line 3. The new building is designed as a comprehensive hub for consultations, medical assessments, and stem cell therapy procedures. The modern and professional environment reflects the trust earned over a decade since the company’s inception in 2012.

Advanced Research Center and High-Standard GMP Production

The heart of the new headquarters is the Cell Processing Center (CPC), which adheres to GMP standards certified by the Korean MFDS. EHL BIO focuses on high-level technology for cell isolation and cultivation, ensuring excellent cell survival rates and yields significantly higher than industry standards.

Our laboratories feature Class 100 Clean Rooms equipped with high-efficiency HEPA filters and Air Handling Units (AHU) to maintain peak cleanliness and biosafety. The facility is fully equipped with advanced tools, including Biological Safety Cabinets (BSC), CO2 incubators, and liquid nitrogen storage systems at -196°C to preserve cell integrity for future therapeutic use.

Relocating our headquarters to Apgujeong represents our mission to elevate cell therapy innovation for a better quality of life in our second decade.

R&D Hub for Future Innovations

In addition to the Gangnam office, EHL BIO maintains a crucial research base in Gyeonggi-do, serving as the main driver for developing new biopharmaceuticals like ADSTEM for atopic dermatitis and KDSTEM for chronic kidney disease. These research efforts have been selected for government-level regenerative medicine technology projects and honored with the prestigious 'IR52 Jang Young-shil' Innovation Technology Award.

EHL BIO’s research team continues to develop Exosome and Conditioned Media technologies for both medical and premium skincare applications. Our institutes focus not just on management of diseases but on providing 'Aging Well' solutions to improve quality of life and restoration goals by seamlessly integrating medical and pharmaceutical technologies.

Standardized Service Procedures for Thai Clients

EHL BIO has built trust through a network of partner hospitals in Korea, including EHL Thailand, which provides professional coordination in the Thai language. The process begins with an online consultation for expert medical document review, followed by travel planning to visit the EHL Cell Center in Apgujeong.

Upon arrival in Korea, clients undergo health screenings and sample collection in a safe environment. Cells are then cultured in a GMP facility under quality control according to EHL team assessments. Once ready, clients receive the planned service, followed by continuous monitoring after returning to Thailand to ensure the most effective physical recovery.

Frequently asked questions

Where is the new EHL BIO headquarters located?

It is located at the EHL Building, 4th Floor, 136 Apgujeong-ro, Gangnam-gu, Seoul, South Korea, conveniently accessible via Apgujeong Station Exit 5.

What are the safety standards of the EHL BIO research center?

Our center is GMP-certified by the Korean MFDS, featuring Class 100 laboratories with AHU and HEPA filter systems for cleanliness and safety according to international standards.

What are the restoration goals and quality of life outcomes at EHL BIO?

The primary goal is physical restoration and enhancing the client's quality of life, supported by a production capacity of up to 6,000 cell lots annually, closely monitored according to EHL team assessments for effective recovery results.